Published in J Biotechnol on September 18, 2006
The inside out of lentiviral vectors. Viruses (2011) 0.85
Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells. J Gene Med (2010) 0.81
Post-transcriptionally regulated expression system in human xenogeneic transplantation models. Mol Ther (2011) 0.78
A modular system to evaluate the efficacy of protease inhibitors against HIV-2. PLoS One (2014) 0.76
Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System. Viruses (2015) 0.75
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol (2005) 1.80
Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma. AIDS Res Hum Retroviruses (2009) 1.66
Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol (2005) 1.50
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27
Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain (2003) 1.10
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis. J Biol Chem (2002) 1.09
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors. Hepatology (2003) 1.00
Pharmaceutical therapies to recode nonsense mutations in inherited diseases. Pharmacol Ther (2012) 1.00
High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. J Biol Chem (2011) 0.97
Human immunodeficiency virus type 1 latency model for high-throughput screening. Antimicrob Agents Chemother (2005) 0.94
Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibody. J Immunol (2009) 0.91
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma. Blood (2010) 0.89
Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood (2004) 0.88
Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays. Genes Chromosomes Cancer (2008) 0.84
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 0.83
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication. Retrovirology (2013) 0.82
In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells. Eur J Immunol (2009) 0.81
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid. Stem Cell Res Ther (2011) 0.80
The influence of follicular migration on T-cell differentiation. Immunology (2004) 0.79
Post-transcriptionally regulated expression system in human xenogeneic transplantation models. Mol Ther (2011) 0.78
HIV type-1 latency: targeted induction of proviral reservoirs. Antivir Chem Chemother (2009) 0.77
Choice and use of appropriate packaging cell types. Methods Mol Biol (2003) 0.77
Host stem cells can selectively reconstitute missing lymphoid lineages in irradiation bone marrow chimeras. Blood (2003) 0.77
Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2. J Virol (2006) 0.77
New strategies for immune-mediated anti-viral drug and vaccine development. Curr Pharm Des (2006) 0.75
Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency. Autoimmunity (2010) 0.75
Isolation of multilineage progenitors from mouse brain. In Vitro Cell Dev Biol Anim (2013) 0.75